New Alzheimer’s drug could bring hope to patients, but could be out of reach for people on Medicare

The Food and Drug Administration is set to announce soon whether it will grant full approval to lecanemab for the treatment of Alzheimer's.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.